Trial Profile
The gastrointestinal behavior of aprepitant in healthy volunteers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2020
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary)
- Indications Chemotherapy-induced nausea and vomiting; Postoperative nausea and vomiting
- Focus Pharmacokinetics
- 03 Apr 2020 Status changed from recruiting to completed.
- 19 Aug 2016 New trial record